CBLI

Cleveland BioLabs to Present at BARDA and NIAID Sponsored Symposium on Development of Radiation Medical Countermeasures

[at noodls] – Download PDF BUFFALO, N.Y., Jan. 24, 2013 (GLOBE NEWSWIRE) — Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that the Company was invited to present at a symposium hosted by the Biomedical Advanced … moreView todays social media effects on CBLIView the latest stocks trending across Twitter. Click to view dashboardSee who Cleveland is hiring next, click here to […]

Panacela Labs, a Subsidiary of Cleveland BioLabs, Signs Contract for Approximately $4.6 Million With Russian Ministry of Industry and Trade for Development of Xenomycins

[at noodls] – Download PDF BUFFALO, N.Y., Nov. 27, 2012 (GLOBE NEWSWIRE) — Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Panacela Labs, Inc. today announced award of a contract valued at 146 million rubles, or approximately … moreView todays social media effects on CBLIView the latest stocks trending across Twitter. Click to view dashboard […]

Cleveland BioLabs Reports Third Quarter 2012 Financial Results and Development Progress

[at noodls] – Download PDF BUFFALO, N.Y., Nov. 8, 2012 (GLOBE NEWSWIRE) — Cleveland BioLabs, Inc. (Nasdaq:CBLI) today reported financial results and development progress for the third quarter and nine months ended … moreView todays social media effects on CBLIView the latest stocks trending across Twitter. Click to view dashboard […]

Cleveland BioLabs to Report Third Quarter Financial Results and Provide Operational Update on November 8

[at noodls] – Download PDF BUFFALO, N.Y., Oct. 30, 2012 (GLOBE NEWSWIRE) — Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that on November 8, 2012, before the market opens, it will report its second quarter … moreView todays social media effects on CBLIView the latest stocks trending across Twitter. Click to view dashboard […]

Department of Defense Chemical Biological and Medical Systems Continues Funding Under Development Contract With Cleveland BioLabs for Entolimod(TM) (CBLB502)

[at noodls] – Download PDF BUFFALO, N.Y., Oct. 25, 2012 (GLOBE NEWSWIRE) — Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that the U.S. Department of Defense (DoD) Chemical Biological and Medical Systems (CBMS) … moreView todays social media effects on CBLIView the latest stocks trending across Twitter. Click to view dashboard […]

Cleveland BioLabs Prices $15 Million Public Offering of Common Stock and Warrants

[at noodls] – Download PDF BUFFALO, N.Y., Oct. 19, 2012 (GLOBE NEWSWIRE) — Cleveland BioLabs, Inc. (Nasdaq:CBLI) announced today that it has priced an underwritten public offering of 7,500,000 units at a price to the … moreView todays social media effects on CBLIView the latest stocks trending across Twitter. Click to view dashboard […]

Cleveland BioLabs Announces Proposed Public Offering of Common Stock and Warrants

[at noodls] – Download PDF BUFFALO, N.Y., Oct. 18, 2012 (GLOBE NEWSWIRE) — Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced today that it intends to offer shares of its common stock and warrants to purchase shares … moreView todays social media effects on CBLIView the latest stocks trending across Twitter. Click to view dashboard […]

Cleveland BioLabs Submits Proposal to BARDA for Development Funding for Entolimod(TM) (CBLB502)

[at noodls] – Download PDF BUFFALO, N.Y., Oct. 18, 2012 (GLOBE NEWSWIRE) — Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced it has submitted a proposal to the Biomedical Advanced Research and Development Authority … moreView todays social media effects on CBLIView the latest stocks trending across Twitter. Click to view dashboard […]